244 related articles for article (PubMed ID: 32513422)
1. Updates in hereditary breast cancer genetic testing and practical high risk breast management in gene carriers.
Pederson HJ; Noss R
Semin Oncol; 2020 Aug; 47(4):182-186. PubMed ID: 32513422
[TBL] [Abstract][Full Text] [Related]
2. A clinically structured and partnered approach to genetic testing in Trinidadian women with breast cancer and their families.
Donenberg T; George S; Ali J; Bravo G; Hernandez K; Sookar N; Ashing KT; Narod SA; Akbari MR; Hurley J
Breast Cancer Res Treat; 2019 Apr; 174(2):469-477. PubMed ID: 30515680
[TBL] [Abstract][Full Text] [Related]
3. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
4. An update on genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.
Piccinin C; Panchal S; Watkins N; Kim RH
Expert Rev Anticancer Ther; 2019 Sep; 19(9):787-801. PubMed ID: 31469018
[No Abstract] [Full Text] [Related]
5. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary breast and ovarian cancer - indications for genetic testing, counseling and options for mutation carriers].
Bürki N
Ther Umsch; 2010 Jul; 67(7):359-66. PubMed ID: 20577964
[TBL] [Abstract][Full Text] [Related]
7. The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition.
Afghahi A; Kurian AW
Curr Treat Options Oncol; 2017 May; 18(5):27. PubMed ID: 28439798
[TBL] [Abstract][Full Text] [Related]
8. A new paradigm of genetic testing for hereditary breast/ovarian cancers.
Kwong A; Chen JW; Shin VY
Hong Kong Med J; 2016 Apr; 22(2):171-7. PubMed ID: 26980575
[TBL] [Abstract][Full Text] [Related]
9. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
10. Multi-Gene Panel Testing of 23,179 Individuals for Hereditary Cancer Risk Identifies Pathogenic Variant Carriers Missed by Current Genetic Testing Guidelines.
Neben CL; Zimmer AD; Stedden W; van den Akker J; O'Connor R; Chan RC; Chen E; Tan Z; Leon A; Ji J; Topper S; Zhou AY
J Mol Diagn; 2019 Jul; 21(4):646-657. PubMed ID: 31201024
[TBL] [Abstract][Full Text] [Related]
11. Global Disparities in Breast Cancer Genetics Testing, Counselling and Management.
Yip CH; Evans DG; Agarwal G; Buccimazza I; Kwong A; Morant R; Prakash I; Song CY; Taib NA; Tausch C; Ung O; Meterissian S
World J Surg; 2019 May; 43(5):1264-1270. PubMed ID: 30610270
[TBL] [Abstract][Full Text] [Related]
12. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
13. Strategies to enhance identification of hereditary breast cancer gene carriers.
Reid S; Spalluto LB; Pal T
Expert Rev Mol Diagn; 2020 Sep; 20(9):861-865. PubMed ID: 32856489
[No Abstract] [Full Text] [Related]
14. Universal Genetic Testing for All Breast Cancer Patients.
Copur MS
Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469901
[TBL] [Abstract][Full Text] [Related]
15. Utility of Expedited Hereditary Cancer Testing in the Surgical Management of Patients with a New Breast Cancer Diagnosis.
Theobald KA; Susswein LR; Marshall ML; Roberts ME; Mester JL; Speyer D; Williams RNW; Knapke SC; Solomon SR; Murphy PD; Klein RT; Hruska KS; Solomon BD
Ann Surg Oncol; 2018 Nov; 25(12):3556-3562. PubMed ID: 30167906
[TBL] [Abstract][Full Text] [Related]
16. Identification and Management of
Pal T; Brzosowicz J; Valladares A; Wiesner GL; Laronga C
South Med J; 2017 Oct; 110(10):643-648. PubMed ID: 28973705
[TBL] [Abstract][Full Text] [Related]
17. Gene panel testing for hereditary breast cancer.
Winship I; Southey MC
Med J Aust; 2016 Mar; 204(5):188-90. PubMed ID: 26985847
[TBL] [Abstract][Full Text] [Related]
18. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient.
Njoroge SW; Burgess KR; Cobleigh MA; Alnajar HH; Gattuso P; Usha L
Breast Cancer Res Treat; 2017 Nov; 166(1):315-319. PubMed ID: 28702897
[TBL] [Abstract][Full Text] [Related]
19. The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
Eliade M; Skrzypski J; Baurand A; Jacquot C; Bertolone G; Loustalot C; Coutant C; Guy F; Fumoleau P; Duffourd Y; Arnould L; Delignette A; Padéano MM; Lepage C; Raichon-Patru G; Boudrant A; Bône-Lépinoy MC; Villing AL; Charpin A; Peignaux K; Chevrier S; Vegran F; Ghiringhelli F; Boidot R; Sevenet N; Lizard S; Faivre L
Oncotarget; 2017 Jan; 8(2):1957-1971. PubMed ID: 27779110
[TBL] [Abstract][Full Text] [Related]
20. Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
Cobain EF; Milliron KJ; Merajver SD
Semin Oncol; 2016 Oct; 43(5):528-535. PubMed ID: 27899183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]